Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study

J Clin Pathol. 2021 Dec;74(12):816-818. doi: 10.1136/jclinpath-2020-207121. Epub 2020 Dec 30.
No abstract available

Keywords: hematologic diseases; immunohistochemistry; lymphoma; proto-oncogene proteins c-myc.

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / genetics
  • Disease Progression
  • Female
  • Humans
  • Immunohistochemistry
  • Lymphoma, Large B-Cell, Diffuse / chemistry*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / genetics
  • Lymphoma, Large B-Cell, Diffuse / mortality
  • Male
  • Middle Aged
  • Progression-Free Survival
  • Proto-Oncogene Proteins c-bcl-2 / analysis*
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-myc / analysis*
  • Proto-Oncogene Proteins c-myc / genetics
  • Retrospective Studies
  • Time Factors
  • Translocation, Genetic

Substances

  • BCL2 protein, human
  • Biomarkers, Tumor
  • MYC protein, human
  • Proto-Oncogene Proteins c-bcl-2
  • Proto-Oncogene Proteins c-myc